This section is prepared for health professionals only
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
16 mg/5 mg
Hypertension
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
16 mg/10 mg
Hypertension
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
8 mg/5 mg
Hypertension
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
16 mg/5 mg/12.5 mg
Hypertension
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
16 mg/10 mg/12.5 mg
Hypertension
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
15 mg
Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF)
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
20 mg
Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF)
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
60 mg
Prevention of atherothrombotic events
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
90 mg
Prevention of atherothrombotic events
Pharmaceutical Form
Strengths
Area of Use
Tablet
1000 mg
Vascular insufficiencies as in hemorrhoids, arterial insufficiencies that causes pain and cramps in legs and microcirculation insufficiencies as in diabetic neuropathy
Pharmaceutical Form
Strengths
Area of Use
Capsule
500 mg
Vascular insufficiencies as in hemorrhoids, arterial insufficiencies that causes pain and cramps in legs and microcirculation insufficiencies as in diabetic neuropathy
Pharmaceutical Form
Strengths
Area of Use
Tablet
12.5 mg
Hypertension, coronary heart disease
Pharmaceutical Form
Strengths
Area of Use
Tablet
25 mg
Hypertension, coronary heart disease
Pharmaceutical Form
Strengths
Area of Use
Tablet
6.25 mg
Hypertension, coronary heart disease
Pharmaceutical Form
Strengths
Area of Use
Retard tablet
400 mg
Occlusive diseases of peripheral arteries, arteriovenous circulatory disorders
Pharmaceutical Form
Strengths
Area of Use
Ampoule
100 mg/5 ml
Occlusive diseases of peripheral arteries, arteriovenous circulatory disorders